This effect impeded the binding of kinase (MEK1) to the substrate (ERK2), preventing the phosphorylation of ERK2, finally resulting in suppression of ICC proliferation and metastasis (Fig. 7G). Here, MAP2K1 is linked to intrahepatic cholangiocarcinoma.